Meet the Investigators: Researchers who study lung cancer.
These scientists dedicate their professional lives to the study of lung cancer. The name for these scientists is “investigators.” Some Lung Cancer Investigators look for new medicines for lung cancer. Some look for ways to recognize lung cancer earlier. All work to find ways to help lung cancer patients live longer, fuller lives.
Some of the investigators here specialize in small cell lung cancer. They are working to find new treatments for better small cell lung cancer survival rates.
Other investigators here specialize in non-small cell lung cancer. Adenocarcinoma and Squamous Cell Carcinoma are both types of non-small cell lung cancer. Some investigators are working to find new treatments to “target” mutational changes in cancer cells. These mutational changes include ALK, EGFR, ROS1, BRAF and more.
There are also investigators listed here who work in the field of immunotherapy. Immunotherapy is the latest exciting research breakthrough for lung cancer. Immunotherapies stimulate or use a person’s own immune system to attack cancer cells. In recent years, the FDA has approved several immunotherapies to be used to treat lung cancer, with more in the pipeline awaiting approval.
Among this group of dedicated scientists, are investigators who have been recipients of research grants awarded by Lung Cancer Foundation of America. These investigators presented the “best science” proposal to LCFA’s Scientific Advisory Board and were chosen to receive a significant lung cancer research grant.
Each of these scientists has a unique story. Watch these videos as they explain how their research helps lung cancer patients and the families and caregivers who support them.
Jessica Donington NYU School of Medicine Meet the Investigator Dr. Jessica Donington, a General Thoracic Surgeon and Associate Professor of Cardiothoracic Surgery at NYU School of Medicine. She is the director of the NYU Thoracic Oncology Translational Laboratory and chief of General Thoracic Surgery at Bellevue Hospital. Dr. Donington's research centers around lung cancer early […]
Dr. David Johnson UT Southwestern Medical Center Dr. David H. Johnson is the Donald W. Seldin Distinguished Chair in Internal Medicine and Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas. He is a board certified medical oncologist who specializes in experimental therapeutics and the treatment of lung cancers. […]
Dr. Julie Brahmer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Meet Dr. Julie Brahmer, global thought leader in the emerging field of immunotherapy. Dr. Brahmer’s research and clinical practice focus on the development of new therapies, including immunotherapies, for the treatment and prevention of lung cancer and mesothelioma. She was involved in the phase […]
Dr. Alice Shaw Center for Thoracic Cancers at Massachusetts General Hospital Her patients call her a super hero and a rock star, but, in real life, Dr. Alice Shaw is an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital and an associate professor of medicine at Harvard Medical School. In addition […]
Thanks to our generous sponsors